Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PCAR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Mark C. Pigott Executive Chairman, Director | PCAR PACCAR Inc. | Sale | 0 | $106.13 | $46.06 Sale | Form 4 ↗ |
| Jul 31, 2026 | Paulo Henrique Bolgar Vice President | PCAR PACCAR Inc. | Sale | 2,897 | $133.90 | $387.9K Sale | Form 4 ↗ |
| Jul 31, 2026 | Brice J. Poplawski Sr. Vice President & CFO | PCAR PACCAR Inc. | Sale | 1,970 | $132.50 | $261.0K Sale | Form 4 ↗ |
| Jul 31, 2026 | William Lance Walters Vice President | PCAR PACCAR Inc. | Sale | 1,000 | $133.50 | $133.5K Sale | Form 4 ↗ |
| Jul 31, 2026 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 50,975 | $133.07 | $6.8M Sale | Form 4 ↗ |
| Feb 12, 2026 | Brice J. Poplawski Sr. Vice President & CFO | PCAR PACCAR Inc. | Sale | 2,200 | $130.41 | $286.9K Sale | Form 4 ↗ |
| Feb 11, 2026 | Craig R. Gryniewicz Vice President | PCAR PACCAR Inc. | Sale | 8,748 | $129.00 | $1.1M Sale | Form 4 ↗ |
| Feb 4, 2026 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 9,258 | $129.70 | $1.2M Sale | Form 4 ↗ |
| Feb 3, 2026 | C. Michael Dozier EXECUTIVE VICE PRESIDENT | PCAR PACCAR Inc. | Sale | 79,076 | $127.92 | $10.1M Sale | Form 4 ↗ |
| Feb 3, 2026 | Laura J. Bloch Senior Vice President | PCAR PACCAR Inc. | Sale | 8,832 | $125.75 | $1.1M Sale | Form 4 ↗ |
| Feb 3, 2026 | Kevin D. Baney Executive Vice President | PCAR PACCAR Inc. | Sale | 9,672 | $126.53 | $1.2M Sale | Form 4 ↗ |
| Feb 3, 2026 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 9,258 | $127.44 | $1.2M Sale | Form 4 ↗ |
| Feb 2, 2026 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 9,258 | $123.65 | $1.1M Sale | Form 4 ↗ |
| Feb 2, 2026 | Brice J. Poplawski Sr. Vice President & CFO | PCAR PACCAR Inc. | Sale | 2,200 | $123.99 | $272.8K Sale | Form 4 ↗ |
| Feb 2, 2026 | Laura J. Bloch Senior Vice President | PCAR PACCAR Inc. | Sale | 6,588 | $123.57 | $814.1K Sale | Form 4 ↗ |
| Jan 30, 2026 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 9,258 | $122.39 | $1.1M Sale | Form 4 ↗ |
| Jan 30, 2026 | Paulo Henrique Bolgar Vice President | PCAR PACCAR Inc. | Sale | 12,183 | $122.43 | $1.5M Sale | Form 4 ↗ |
| Oct 27, 2025 | Brice J. Poplawski Sr. Vice President & CFO | PCAR PACCAR Inc. | Sale | 3,369 | $101.15 | $340.8K Sale | Form 4 ↗ |
| Jul 29, 2025 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 39,965 | $99.52 | $4.0M Sale | Form 4 ↗ |
| Jul 25, 2025 | Brice J. Poplawski Sr. Vice President & CFO | PCAR PACCAR Inc. | Sale | 5,000 | $100.94 | $504.7K Sale | Form 4 ↗ |
| May 6, 2025 | Pierre R. Breber Director | PCAR PACCAR Inc. | Buy | 5,000 | $89.78 | $448.9K Buy | Form 4 ↗ |
| Feb 19, 2025 | Michael K. Walton VICE PRESIDENT/GENERAL COUNSEL | PCAR PACCAR Inc. | Sale | 6,000 | $106.13 | $636.8K Sale | Form 4 ↗ |
| Feb 18, 2025 | Harrie Schippers PRESIDENT & CFO | PCAR PACCAR Inc. | Sale | 28,676 | $105.97 | $3.0M Sale | Form 4 ↗ |
| Jan 31, 2025 | Darrin C. Siver EXECUTIVE VICE PRESIDENT | PCAR PACCAR Inc. | Sale | 103,671 | $111.56 | $11.6M Sale | Form 4 ↗ |
| Jan 31, 2025 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 25,200 | $110.98 | $2.8M Sale | Form 4 ↗ |
| Jan 31, 2025 | Todd R. Hubbard VICE PRESIDENT | PCAR PACCAR Inc. | Sale | 2,000 | $112.05 | $224.1K Sale | Form 4 ↗ |
| Nov 1, 2024 | R. Preston Feight CHIEF EXECUTIVE OFFICER, Director | PCAR PACCAR Inc. | Sale | 27,191 | $103.52 | $2.8M Sale | Form 4 ↗ |
| Oct 28, 2024 | Kevin D. Baney Senior Vice President | PCAR PACCAR Inc. | Sale | 9,894 | $107.00 | $1.1M Sale | Form 4 ↗ |
| Oct 28, 2024 | Harrie Schippers PRESIDENT & CFO | PCAR PACCAR Inc. | Sale | 20,000 | $106.93 | $2.1M Sale | Form 4 ↗ |
| Oct 25, 2024 | Todd R. Hubbard VICE PRESIDENT | PCAR PACCAR Inc. | Sale | 3,230 | $107.27 | $346.5K Sale | Form 4 ↗ |
| Oct 25, 2024 | Brice J. Poplawski Vice President & Controller | PCAR PACCAR Inc. | Sale | 3,000 | $106.07 | $318.2K Sale | Form 4 ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:09 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances